Miguel Mosteiro
Papers
1
Total Citations
2
H-Index
1
About
Dr. Miguel Mosteiro is a pioneering thoracic surgeon whose research centers on robotic-assisted lung surgery, neoadjuvant therapy for non-small cell lung cancer (NSCLC), and optimizing perioperative outcomes. His major contributions include demonstrating that neoadjuvant chemoimmunotherapy, while elevating surgical complexity in robotic lobectomy, does not compromise postoperative safety or recovery—a critical finding that supports expanding multimodal treatment for locally advanced NSCLC. His 2024 study on this topic, though early in citation impact, addresses a pressing clinical question: whether modern induction regimens increase technical difficulty or complication rates in minimally invasive surgery. By showing comparable outcomes between neoadjuvant-treated and upfront surgery patients, Mosteiro provides evidence that robotic platforms can safely accommodate the fibrotic tissue changes induced by immunotherapy. His work bridges oncology and surgical innovation, offering surgeons confidence to integrate cutting-edge systemic therapies with advanced minimally invasive techniques. As a rising voice in thoracic oncology, Mosteiro’s research directly informs clinical decision-making for patients with stage II–III NSCLC, where the interplay between immunotherapy and surgical precision is reshaping treatment paradigms.
Research Focus
Key Achievements
Top Papers
- 1